In the management of pulmonary embolism, thrombolysis is contraindicated in patients within 10 days of major surgery. Which option would be contraindicated in such a patient?

Enhance your readiness for the Physician Assistant Clinical Knowledge Rating and Assessment Tool (PACKRAT) 4 Exam. Utilize our flashcards and multiple-choice questions, complete with hints and explanations, to ace your upcoming test!

Multiple Choice

In the management of pulmonary embolism, thrombolysis is contraindicated in patients within 10 days of major surgery. Which option would be contraindicated in such a patient?

Explanation:
Thrombolysis is contraindicated because providing clot-busting therapy soon after major surgery carries a high risk of serious bleeding at the surgical site and other sites. Within about 10 days of surgery, wound healing is incomplete, so systemic fibrinolysis can lead to postoperative hemorrhage, wound dehiscence, or other catastrophic bleeding. That danger makes thrombolysis unsafe in this setting. Alternatives to treat PE when thrombolysis is not an option include anticoagulation to prevent new clots, surgical embolectomy if the patient is unstable or thrombolysis isn’t feasible, and an inferior vena cava filter to reduce recurrence risk when anticoagulation is contraindicated or ineffective.

Thrombolysis is contraindicated because providing clot-busting therapy soon after major surgery carries a high risk of serious bleeding at the surgical site and other sites. Within about 10 days of surgery, wound healing is incomplete, so systemic fibrinolysis can lead to postoperative hemorrhage, wound dehiscence, or other catastrophic bleeding. That danger makes thrombolysis unsafe in this setting.

Alternatives to treat PE when thrombolysis is not an option include anticoagulation to prevent new clots, surgical embolectomy if the patient is unstable or thrombolysis isn’t feasible, and an inferior vena cava filter to reduce recurrence risk when anticoagulation is contraindicated or ineffective.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy